Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
Several stocks are experiencing significant pre-market movements. Immunic, Inc. (NASDAQ:IMUX) shares gained 13.2% after positive interim data from a Phase 2 trial. SuperCom Ltd. (NASDAQ:SPCB), Tempest Therapeutics, Inc. (NASDAQ:TPST), Mobilicom Limited (NASDAQ:MOB), SMX (Security Matters) Public Limited Company (NASDAQ:SMX), ContraFect Corporation (NASDAQ:CFRX), and ParaZero Technologies Ltd. (NASDAQ:PRZO) also saw pre-market gains. On the other hand, Borqs Technologies, Inc. (NASDAQ:BRQS), Phoenix Motor Inc. (NASDAQ:PEV), Atreca, Inc. (NASDAQ:BCEL), RVL Pharmaceuticals plc (NASDAQ:RVLP), Molekule Group, Inc. (NASDAQ:MKUL), Windtree Therapeutics, Inc. (NASDAQ:WINT), Applied UV, Inc. (NASDAQ:AUVI), Vascular Biogenics Ltd. (NASDAQ:VBLT), Maison Solutions Inc. (NASDAQ:MSS), and Future FinTech Group Inc. (NASDAQ:FTFT) experienced pre-market losses.
October 10, 2023 | 12:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Borqs Technologies, Inc. fell 50.8% in pre-market trading after a 1-for-12 reverse stock split.
A reverse stock split often indicates a company is in trouble and is trying to boost its stock price to avoid delisting. This can lead to decreased investor confidence and a drop in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Immunic, Inc. shares gained 13.2% in pre-market trading after positive interim data from a Phase 2 trial.
Positive interim data from a Phase 2 trial is a strong positive signal for a biotech company like Immunic, Inc., which can lead to increased investor confidence and a rise in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100